Articles

AI may pose a threat to software companies that charge customers per seat or employee, but IBM offers relative stability in part due to a different business model.

The $9 billion deal is a play on AI power needs, but one analyst thinks the purchase price undervalues Core Scientific’s business and potential.

Companies passing the screen for low valuations, rapid dividend growth and business-expansion prospects include PepsiCo and Occidental Petroleum.

Two different measures tell a similar story

There are plenty of choices. They don’t have to be difficult.

MicroStrategy made news by not buying bitcoin in the latest week, marking its first pause in three months.

Meta’s push for top-tier AI talent, which could cost up to $1.4 billion, raises questions about its approach to competing with other companies, a Rosenblatt analyst says.

The new chief executive of Stellantis faces a mountain of problems, and it’s too early for investors to go bottom fishing in the Jeep and Ram truck maker, a new research note published Monday says.

J.P. Morgan’s Tien-tsin Huang initiates coverage of bank services company with an overweight rating and a projected 25% stock-price gain over the next 12 months

“If I predecease my husband, my will states that my son will receive half of this account.”

An analyst downgrades Wells Fargo’s stock and upgrades U.S. Bancorp as regional banks gain favor after big runups by the largest banks.

Molina Healthcare cuts its profit outlook, but its stock is rising after tumbling last week in response to rival Centene’s warning.